Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Swain

Showing results (111-120 of 157) with videos related to

Pageof 16
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 18, 2002
4,4-Disubstituted cyclohexylamine NK(1) receptor antagonists IILaura C Cooper, Emma J Carlson, Jose L Castro, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
2-Aryl indole NK1 receptor antagonists: optimisation of indole substitutionL C Cooper, G G Chicchi, K Dinnell, et al.
Neurology|November 26, 2013
Quality improvement in neurology: amyotrophic lateral sclerosis quality measures: report of the quality measurement and reporting subcommittee of the American Academy of NeurologyRobert G Miller, Benjamin Rix Brooks, Rebecca J Swain-Eng, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 9, 2014
Quality improvement in neurology: amyotrophic lateral sclerosis quality measures. Report of the Quality Measurement and Reporting Subcommittee of the American Academy of NeurologyRobert G Miller, Benjamin Rix Brooks, Rebecca J Swain-Eng, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2005
Novel lactam NK1 antagonists with anti-emetic activityGregory J Hollingworth, Emma J Carlson, José L Castro, et al.
Journal of Medicinal Chemistry|November 7, 1998
4,4-Disubstituted piperidine high-affinity NK1 antagonists: structure-activity relationships and in vivo activityG I Stevenson, I Huscroft, A M MacLeod, et al.
European Journal of Pharmacology|May 20, 1997
In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonistsN M Rupniak, F D Tattersall, A R Williams, et al.
Neurology|February 13, 2013
Teleneurology applications: Report of the Telemedicine Work Group of the American Academy of NeurologyLawrence R Wechsler, Jack W Tsao, Steven R Levine, et al.
Open Biology|September 25, 2015
Bifunctional crosslinking ligands for transthyretinP Patrizia Mangione, Stéphanie Deroo, Stephan Ellmerich, et al.
Journal of Medicinal Chemistry|July 19, 1996
N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonistsT Ladduwahetty, R Baker, M A Cascieri, et al.
Pageof 16

Showing results (111-120 of 157) with videos related to

Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry Letters|June 18, 2002
4,4-Disubstituted cyclohexylamine NK(1) receptor antagonists IILaura C Cooper, Emma J Carlson, Jose L Castro, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
2-Aryl indole NK1 receptor antagonists: optimisation of indole substitutionL C Cooper, G G Chicchi, K Dinnell, et al.
Neurology|November 26, 2013
Quality improvement in neurology: amyotrophic lateral sclerosis quality measures: report of the quality measurement and reporting subcommittee of the American Academy of NeurologyRobert G Miller, Benjamin Rix Brooks, Rebecca J Swain-Eng, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 9, 2014
Quality improvement in neurology: amyotrophic lateral sclerosis quality measures. Report of the Quality Measurement and Reporting Subcommittee of the American Academy of NeurologyRobert G Miller, Benjamin Rix Brooks, Rebecca J Swain-Eng, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2005
Novel lactam NK1 antagonists with anti-emetic activityGregory J Hollingworth, Emma J Carlson, José L Castro, et al.
Journal of Medicinal Chemistry|November 7, 1998
4,4-Disubstituted piperidine high-affinity NK1 antagonists: structure-activity relationships and in vivo activityG I Stevenson, I Huscroft, A M MacLeod, et al.
European Journal of Pharmacology|May 20, 1997
In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonistsN M Rupniak, F D Tattersall, A R Williams, et al.
Neurology|February 13, 2013
Teleneurology applications: Report of the Telemedicine Work Group of the American Academy of NeurologyLawrence R Wechsler, Jack W Tsao, Steven R Levine, et al.
Open Biology|September 25, 2015
Bifunctional crosslinking ligands for transthyretinP Patrizia Mangione, Stéphanie Deroo, Stephan Ellmerich, et al.
Journal of Medicinal Chemistry|July 19, 1996
N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonistsT Ladduwahetty, R Baker, M A Cascieri, et al.
Pageof 16